Panagora Asset Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-199,945
Closed -$1.16M 1582
2022
Q1
$1.16M Sell
199,945
-401,576
-67% -$2.39M 0.01% 869
2021
Q4
$4.51M Sell
601,521
-9,069
-1% -$78.8K 0.02% 429
2021
Q3
$5.5M Buy
610,590
+4,693
+0.8% +$46.4K 0.03% 405
2021
Q2
$7.25M Sell
605,897
-29,671
-5% -$336K 0.04% 365
2021
Q1
$7.96M Sell
635,568
-16,963
-3% -$229K 0.04% 358
2020
Q4
$10.2M Buy
652,531
+167,489
+35% +$1.96M 0.06% 276
2020
Q3
$4.58M Buy
485,042
+17,955
+4% +$194K 0.03% 414
2020
Q2
$4.18M Buy
467,087
+104,326
+29% +$968K 0.03% 449
2020
Q1
$2.31M Buy
362,761
+194,758
+116% +$1.45M 0.02% 551
2019
Q4
$1.41M Buy
+168,003
New +$1.54M 0.01% 920
2017
Q3
Sell
-2,693
Closed -$24K 2473
2017
Q2
$24K Buy
+2,693
New +$17.3K ﹤0.01% 2223
2016
Q2
Sell
-4,469
Closed -$27K 2344
2016
Q1
$27K Hold
4,469
﹤0.01% 2102
2015
Q4
$41K Buy
4,469
+497
+13% +$3.83K ﹤0.01% 2028
2015
Q3
$22K Buy
+3,972
New +$32.8K ﹤0.01% 2129
2015
Q2
Sell
-12,828
Closed -$201K 2465
2015
Q1
$201K Buy
+12,828
New +$198K ﹤0.01% 1666

Other funds holding SGMO

Panagora Asset Management's SGMO Position: Q2 2022 in Review

Panagora Asset Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 199,945 shares — an estimated $1.16M sold.

Panagora Asset Management first reported a position in SGMO in Q1 2015 and held it in 15 quarters. The position peaked at $10.2M in Q4 2020. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • Panagora Asset Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Panagora Asset Management sold 199,945 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $1.16M.
  • Panagora Asset Management first reported a position in SANGAMO THERAPEUTICS INC in Q1 2015 and held it in 15 quarters.
  • Panagora Asset Management's SANGAMO THERAPEUTICS INC position peaked at $10.2M in Q4 2020.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on Panagora Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.